Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > results are good

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Nov 30, 2021 2:16am

202 Views

Post# 34178753

RE:RE:RE:RE:RE:results are good

I agree menoalittle, but then again, we the lowly retailers have been beat into submission on our expectations. TLT should be over $1 already IMO just the fact that they're is in a bona-fide Ph2 trial which would be a better sp platform to start with after these fantastic results. At some point TLT needs to emerge from it's 'under the radar' status. What will it take? no answers here....

menoalittle wrote: >> an FDA response in Q2. Would be happy to break $1

quite frankly, I suspect news of a BTD app being submitted will take over twice that

but, what do I know, eh?